(MedPage Today) -- This latest report from an ongoing Journal Sentinel/MedPage Today investigation details the story behind the 2009 publication of a study that was designed as a key part of a campaign to win FDA approval for a second generation bone morphogenetic protein-2 product for use in spinal fusion...

BMP-2 Researchers Minimized Cancer Finding (click here for the full article at MedPage Today)